DPP-4 helps in the hydrolysis of incretins which prohibit the functions of hormones; several clinical trials and in vivo experimental animal models postulate that DPP-IV inhibitors have demonstrated high therapeutic potential in long-term therapy of T2DM decreases diseases progression and are being used in treating hyperglycemia [25,26]. This evidence concerns the gene GCG and type 2 diabetes mellitus.